DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors. (2019)
Attributed to:
Non-genetic heterogeneity in response to anti-mitotic chemotherapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ccell.2019.02.004
PubMed Identifier: 30889383
Publication URI: http://europepmc.org/abstract/MED/30889383
Type: Journal Article/Review
Volume: 35
Parent Publication: Cancer cell
Issue: 3
ISSN: 1535-6108